Literature DB >> 1569141

A rat model of reproducible cerebral infarction using thrombotic blood clot emboli.

K Overgaard1, T Sereghy, G Boysen, H Pedersen, S Høyer, N H Diemer.   

Abstract

The purpose of this study was the development of a model of embolic stroke with high reproducibility concerning infarct volume. In 37 male Sprague-Dawley rats, the internal carotid artery was embolized with in vitro preformed suspensions of autologous microemboli resembling arterial thrombi. With a method of continuous flow through the carotid arterial catheter, reflux of blood with uncontrolled clotting and embolization was avoided, thereby providing control animals free of ischemic damage. The embolized animals had arterial occlusions on angiograms immediately after embolization and no spontaneous recanalization on angiograms 2 h later. The cerebral blood flow measured by the intra-arterial 133Xe injection method decreased to 21-37% of baseline values. All embolized animals developed hemiparesis with spontaneous circling behavior, embolization with more than 150 microliters clot suspension resulted in hemispherical infarcts. There was a strong statistically significant correlation between amount of emboli, rate of vascular occlusion, and volume of infarcted tissue. This is the first model presented utilizing autologous in vitro microemboli imitating "white" arterial thrombi. The animals developed infarction, resembling human stroke.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569141     DOI: 10.1038/jcbfm.1992.66

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  26 in total

1.  Site-specific thromboembolism: a novel animal model for stroke.

Authors:  Andrew J Ringer; Lee R Guterman; L Nelson Hopkins
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

2.  Focal embolic cerebral ischemia in the rat.

Authors:  Li Zhang; Rui Lan Zhang; Quan Jiang; Guangliang Ding; Michael Chopp; Zheng Gang Zhang
Journal:  Nat Protoc       Date:  2015-03-05       Impact factor: 13.491

3.  A dedicated animal model for mechanical thrombectomy in acute stroke.

Authors:  J Gralla; G Schroth; L Remonda; A Fleischmann; J Fandino; J Slotboom; C Brekenfeld
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

4.  Expression and regulation of miR-449a and AREG in cerebral ischemic injury.

Authors:  Yanhui Yu; Xiuhui Zhang; Zhengmin Han; Weili Zhao; Limin Zhang
Journal:  Metab Brain Dis       Date:  2019-02-18       Impact factor: 3.584

5.  A model of rat embolic cerebral infarction with a quantifiable, autologous arterial blood clot.

Authors:  Norihito Shimamura; Naoya Matsuda; Kiyohide Kakuta; Akiko Narita; Hiroki Ohkuma
Journal:  Transl Stroke Res       Date:  2013-05-25       Impact factor: 6.829

Review 6.  A novel mouse model of thromboembolic stroke.

Authors:  Yingxin Chen; Wenbin Zhu; Wenri Zhang; Nicole Libal; Stephanie J Murphy; Halina Offner; Nabil J Alkayed
Journal:  J Neurosci Methods       Date:  2015-09-18       Impact factor: 2.390

7.  Control of cerebral ischemia with magnetic nanoparticles.

Authors:  Jie-Min Jia; Praveen D Chowdary; Xiaofei Gao; Bo Ci; Wenjun Li; Aditi Mulgaonkar; Erik J Plautz; Gedaa Hassan; Amit Kumar; Ann M Stowe; Shao-Hua Yang; Wei Zhou; Xiankai Sun; Bianxiao Cui; Woo-Ping Ge
Journal:  Nat Methods       Date:  2016-12-12       Impact factor: 28.547

8.  Rodent models of focal cerebral ischemia: procedural pitfalls and translational problems.

Authors:  Stefan Braeuninger; Christoph Kleinschnitz
Journal:  Exp Transl Stroke Med       Date:  2009-11-25

Review 9.  Tumor necrosis factor and stroke: role of the blood-brain barrier.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Prog Neurobiol       Date:  2007-08-06       Impact factor: 11.685

10.  Embolic middle cerebral artery occlusion model using thrombin and fibrinogen composed clots in rat.

Authors:  Ming Ren; Zi-Jing Lin; Hai Qian; Gourav Roy Choudhury; Ran Liu; Hanli Liu; Shao-Hua Yang
Journal:  J Neurosci Methods       Date:  2012-09-14       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.